SNT.ASX: Results of Share Purchase Plan

Results of Share Purchase Plan

Stock	Syntara Ltd (SNT.ASX)
Release Time	10 Jun 2026, 3:07 p.m.
Price Sensitive	Yes

This feature provides summaries of price-sensitive announcements for companies followed by users on InvestorPA. The summaries are generated by large language models so please interpret with care.

Syntara Ltd Successfully Completes Share Purchase Plan

Key Points

Completed Share Purchase Plan with $0.84M in applications
Issued 31,235,279 new shares at A$0.027 each
Total funds raised before costs: approximately $8.84M

Full Summary

Syntara Ltd, a clinical-stage drug development company, announced the successful completion of its Share Purchase Plan (SPP), raising approximately $0.84 million. The SPP offered shares at a 15.6% discount to the last closing price and a 17.6% discount to the 5-day volume weighted average price. A total of 31,235,279 new shares were issued. Combined with a previous $8.0 million placement, Syntara has raised approximately $8.84 million before costs. These funds will support clinical trial readouts, Phase 2b MF study preparation, patent suite strengthening, and offer costs. The company thanks shareholders for their support.

Guidance

Total funds raised: $8.84M; cash runway to Q3 2027

Outlook

Syntara aims to use the funds to progress clinical trials, strengthen its patent suite, and cover offer costs.